Sarcodon Mushrooms: Biologically Active Metabolites by Maria Carla Marcotullio
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
3 
Sarcodon Mushrooms: 
Biologically Active Metabolites 
Maria Carla Marcotullio 
University of Perugia 
Italy 
1. Introduction  
Thelephorales Corn ex. Oberw. belong to the Agaricomycetes (Basidiomycota, Fungi) and 
comprise more than 177 species (Kirk et al., 2008) that are classified into two families: the 
Bankeraceae Donk (mostly with colourless basidiospores) and the Thelephoraceae Chevall. 
(mostly with brown to yellowish basidiospores) (Yorou & Agerer, 2007). Bankeraceae are 
characterized by a typical fenugreek odour, with pileate and stipitate fruit bodies, hydnoid 
to spinose hymenophores with brown and lobed as well as colourless and evenly 
ornamented basidiospores. Bankeraceae comprise 5 distinct genera: Bankera Coker & Beers 
ex Pouzar, Hydnellum P. Karsten, Phellodon P. Karsten, Sarcodon Quél. ex P. Karst and 
Boletopsis Fayod.  
The name Sarcodon was proposed by Quélet in 1878, but as any binomial was  formed, the 
name was established as a genus only later by Karsten (Banker, 1913).  
The name, derived from the ancient greek stems sarco= flesh and odon=tooth, is due to the 
presence of the spines that look like teeth on the hymenophore. For this reason Sarcodon 
species are colloquial called “tooth fungi” (Fig. 1). 
The genus comprises more than 72 species, most of which are not edible, due to the bitter taste. 
Among these species only few have been phytochemically and biologically studied: S. aspratus 
(syn S. imbricatus), S. cyrneus, S. glaucopus, S. leucopus, S. laevigetum (syn. S. laevigatus) and S. 
scabrosus. 
Phytochemical studies were aimed to study either the composition of different extracts or to 
isolate new metabolites and to evaluate biological activity of extracts and isolated compounds. 
2. Phytochemical studies on Sarcodon spp 
2.1 Sarcodon aspratus syn S. imbricatus 
Sarcodon imbricatus (L.) P. Karst. is the current name used for S. aspratus  (Berk.) even though 
several synonyms are used for this mushroom (see Index Fungorum: 
www.indexfungorum.org). It is commonly known as the shingled hedgehog or scaly hedgehog. 
The mushroom has a large, brownish cap with large brown scales and may reach 30 cm in 
diameter. On the underside it sports greyish brittle teeth instead of gills, and has white flesh.  
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Fig. 1. Sarcodon imbricatus (L.: Fr.) Karsten hymenophore 
The fungus can be bitter, although this is less apparent in younger specimens. Submerging 
the mushrooms in boiling water will remove this. It can be pickled or dried and used as 
flavouring. In Bulgaria it is collected, dried and finely ground to be used as an aromatic 
mushroom flour. It is reported as edible, but of poor quality in the United States by some 
sources but as deliciously edible by others. In China Sarcodon aspratus, also known as “black 
tiger’s paw”, is a popular natural edible mushroom. It is used for lowering cholesterol level, 
muscles relaxation and blood circulation. Its special musky aroma enhances the taste in 
meat’s dishes, especially hams (S.K. Kim, 2006), and particularly brings out the sweet 
flavour when making a clear soup out of it.  
Several papers have been published regarding the use of S. aspratus for manufacturing foods 
and beverages (e.g. Hwang & Na, 2009a, 2009b; B.C. Kim et al., 2008, 2009; Jang, 2008; Wang 
& Wang, 2008;  J.K. Kim, 2007).    
2.1.1 Phytochemistry of Sarcodon imbricatus 
In view of its use as a food, the phytochemical composition of S. imbricatus has been studied.  
Proximate constituents (moisture, fat, crude protein, ash and carbohydrates) of this 
mushroom have been reported (Barros et al., 2007a). On the basis of the proximate analysis, 
it can be calculated that a portion of 100 g of this mushroom provides, on average, 24 kcal 
(100 kJ). The analysis of fatty acid composition allowed to determine 15 fatty acids.  
Unsaturated fatty acids (MUFA, monounsaturated fatty acids, 46%, PUFA, polyunsaturated 
fatty acids, 36%) were predominant over SFA (saturated fatty acids, 18%). Methanolic 
extract of S. imbricatus showed the presence (0.5%) of total polyphenols, expressed as g of 
gallic acid /100 g dry weight that justify the radical scavenging activity (DPPH) 
(Marcotullio et al., 2008). On the other hand the amounts of ascorbic acid, ǃ-carotene and 
lycopene found in the mushroom were very low (Barros et al., 2007b). Sterol fraction was 
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Fig. 2. Sarcodon imbricatus  (L.: Fr.) Karsten  
studied by several research groups. In addition to ergosterol, several other ergostane and 
cholestane compounds have been isolated (Huang et al., 2002; Ueno et al., 1999; Marcotullio 
et al., 2008). Particularly interesting is the presence in the methanolic extract of S. imbricatus 
of ergosterol peroxide (or 3-ǃ-hydroxy-5ǂ,8ǂ-epidioxyergosta-6,22-diene) that shows a 
plethora of biological activities, such as antileukemic and anticancer  (Kobori et al., 2006), 
apoptotic-inducing (Takei et al., 2005), and anti-inflammatory (Kobori et al., 2007). It is 
interesting to note that processing and cooking practices determine a lowering of nutrients 
concentrations and of antioxidant activity (Barros et al., 2007c).  
Other interesting metabolites isolated and identified from S. aspratus are polysaccharides. 
Han and coworkers isolated a water soluble polysaccharide (HCP) with molecular mass of 
6.7 x 105 Da (Han et al., 2011). HCP resulted to be a linear glucan with a backbone structure 
of (1→6)-linked--glupyranosyl residues. Another polysaccharide (HBP) with a molecular 
weight of 4.3 x 105 Da was isolated by the same author in 2010. Even in this case the 
backbone structure was constituted by (1→6)-linked--glupyranosyl residues, which 
occasionally branched at O-3 position (Han et al., 2010).  
Other constituents isolated from S. aspratus were ceramide compounds (Yaoita et al., 2002). 
2.2 Sarcodon cyrneus Maas Gest 
Sarcodon cyrneus, according Myco Bank (www.mycobank.org), has a “pileus up to 65 mm 
across, planoconvex to somewhat depressed in centre, finely tomentose at margin, becoming 
felted farther back, or tomentum collapsed to form smooth and shiny pellicle. Stipe 15-30 x 
6-15 mm, broader when fused, equal or somewhat enlarged below, with abruptly pointed 
base, straight to curved, tomentose, in places glabrescent, pale grey-brown, darkening with 
age and becoming more or less concolorous with, pileus, at extreme base with yellowish 
grey mycelium. Spines up to 3 mm long, 0.1-0.3 mm broad, long decurrent, often almost 
reaching base of stipe, crowded, subulate, first whitish, becoming purplish brown. Context 
pallid (whitish suffused with pinkish when fresh, according to the collector), not greenish in 
base of stipe” (Fig. 3). The taste is bitter and the mushroom is not edible. 
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Fig. 3. Sarcodon cyrneus Maas Geest. 
2.2.1 Phytochemistry of Sarcodon cyrneus 
In the literature only two papers regarding the secondary metabolites isolated from S. 
cyrneus have been reported (Marcotullio et al., 2006b; Marcotullio et al., 2007) and they deals 
with the structural identification of five cyathane diterpenes. These compounds were named 
cyrneine A-D (1-4) (Fig. 4) and glaucopine C (7) (Fig. 6). 
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Fig. 4. Structures of cyrneines 
2.3 Sarcodon glaucopus Maas Geest. & Nannf. 
According MycoBank (www.mycobank.org) the mushroom has a “pileus up to 110 mm 
across, plano-convex to somewhat depressed; at first tomentose, then matted, forming a cuticle 
which breaks up into scales near margin, into areoles in centre; scales adhering to appressed, 
yellow-brown with vinaceous shade or pale to dark purplish brown, occasionally locally 
violet-grey (giving a peculiar leaden grey impression), at times very dark brown in centre, 
contrasting with dingy yellowish ground colour, not infrequently covered with minute 
yellowish dots of excreted matter when dried. Stipe 27-75 x 10-40 mm, cylindrical, tapering 
below or somewhat broadened below, tomentose, fibrillose, covered with adnate fibrillose 
squamules or partly matted, dingy whitish, soon pinkish brown to purplish brown above, 
grey-green below, with pointed, whitish base. Spines up to 5 mm long, 0.1-0.2 mm broad, 
whitish, finally purplish brown” (Fig. 5). The taste is bitter and the mushroom is not edible.  
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Fig. 5. Sarcodon glaucopus Maas Geest. & Nannf. 
2.3.1 Phytochemistry of Sarcodon galucopus 
No phytochemical studies regarding proximate composition have been reported for S. 
glaucopus. In the literature there are only two studies on the secondary metabolites of S. 
glaucopus, and they deal with the isolation and structure elucidation of three cyathane 
diterpenes named glaucopine A (5), glaucopine B (6) (Curini et al., 2005) and glaucopine C 
(7) (Marcotullio et al., 2006a) (Fig. 6). 
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Fig. 6. Structures of glaucopines 
2.4 Sarcodon laevigatus (Sw.) P. Karst. 
Index Fungorum (www.indexfungorum.org)  reports for S. laevigatus (syn. S. leucopus, often 
the term S. laevigatum is used instead of S. laevigatus). A description of Sarcodon leucopus 
(Pers.) Maas Geest. & Nannf. has been reported in MycoBank: “Pileus up to ca. 200 mm 
across, planoconvex or slightly depressed, without concentric or radiate markings, at first 
finely felted; felt collapsed to form smooth, more or less shiny, innate-scaly cuticle, the latter 
subsequently radiately rimose near margin, breaking up into areoles in centre, here with 
scales somewhat more pronounced and tips sometimes slightly raised; pale purplish brown 
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on yellowish drab ground colour or a rich purplish brown to dark brown. Stipe 40-80 x 20-60 
mm, cylindrical to ventricose, finely tomentose, later with smooth or innate-scaly cuticle, 
concolorous with pileus or paler, whitish below, after some time with green spots (always?). 
Spines up to c. 15 x 1 mm, whitish, finally purplish brown. Context up to 40 mm thick near 
centre of pileus, whitish, suffused with purplish brown to violet tints, after some time pale 
greenish. Odour commonly experienced as disagreeable. Taste bitter after some time”.  
2.4.1 Phytochemistry of Sarcodon laevigatus or/and S. leucopus 
In the literature no references to S. laevigatus have been reported, while it is possible to find 
two papers referring to S. laevigatum and to S. laevigetum. The first one reports the isolation 
and the structure identification of three p-terphenyls (8-10), of which 8 (named sarcodan) 
was a new compound (Ma et al., 2006). The second report is a Patent and deals with the 
preparation of compound 9 (named B1-V) by extraction from S. laevigetum (Ma, 2009). 
On the other hand, Tringali and coworkers (Tringali et al., 1987) reported the isolation and 
structure identification of several p-terphenyls from Sarcodon leucopus. 
The first two isolated compounds were 10 and 11. (Fig. 8) 
 
 
Fig. 7. Sarcodon leucopus  (Pers.) Maas Geest. & Nannf. 
It is evident from these reports how the correct identification of the species is important for 
preventing mistakes in the identification of new secondary metabolites. 
Later, the same research group isolated other nitrogen-containing p-terphenyl derivatives 
that they named sarcodonins. The first to be isolated was 12 in 2000 (Geraci et al., 2000) and 
other six related compounds (13-18) were isolated in 2004 (Cali et al., 2004) (Fig. 9). 
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Fig. 8. Structures of p-terphenyls isolated from S. laevigatum 
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12   R1=Ac; R2=H;   R3=H;   R4=H
13   R1=H;   R2=H;   R3=H;   R4=H
14   R1=H;   R2=Ac; R3=H;   R4=H
15   R1=Ac; R2=H;   R3=Ac; R4=Ac 
16   R1=Ac; R2=H;   R3=H;   R4=H
17   R1=H;   R2=H;   R3=H;   R4=H
18   R1=H;   R2=Ac; R3=H;   R4=H
 
Fig. 9. Structures of sarcodonins isolated from S. leucopus 
Compounds 13-15 were named sarcodonin , , and Ǆ, respectively, while compounds 16-18 
epi-sarcodonin, epi-sarcodonin  and , respectively. Cali et al., (2004) from the same 
mushroom isolated oxidated sarcodonins and named them sarcoviolin (19) and epi-sarcoviolin 
(20) (Fig. 10). 
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Fig. 10. Structures of sarcoviolins 
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Recently the structures of sarcodonins and sarcoviolins have been revised by synthesis, and 
the new structure for sarcodonin 12 is reported in Fig. 11 (Lin et al., 2011). 
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Fig. 11. Revised structure proposed for sarcodonin 12 
It is very interesting to notice that screening the literature with the term “sarcodonin” 
different structures with the same name have been reported, as we will see checking the 
compounds isolated from S. scabrosus. 
2.5 Sarcodon scabrosus (Fr.) P. Karst. 
Myco Bank describes S. scabrosus  “with pileus up to 120 mm across (fresh), plano-convex, 
more or less deeply depressed in the centre, coarsely scaly, the scales erect in the centre, 
decumbent farther outwards, adnate and woolly near the margin, brown in various 
shades (brick-colour, fulvous, ferruginous, bay) on a fairly pale yellow-brown ground, in 
some specimens passing into a delicate lilac at the margin, with age becoming very dark 
purplish brown, and the scale-tips even blackish, somewhat shiny when dried. Stipe 20-
120 x 10-60 mm (fresh), tapering downwards, usually with pointed base, felted to 
subfibrillose, pinkish brown to brick-colour, becoming concolorous with the pileus, the 
lower part or the base grey-green, when young covered with white mycelium. Spines up 
to 5 mm long (dry), slender (up to 0.3 mm), decurrent, crowded, subulate, long remaining 
yellowish brown, finally purplish brown. Context dingy whitish in the pileus and the top 
of the stipe, vinescent, brownish-marbled with age, grey-green in the base of the stipe. 
Greenish mycelium from the base of the stipe staining dingy pinkish brown to reddish 
brown in KOH solution. Odour of water-melon (Citrullus vulgaris) when cut fresh“ (Fig. 
12). 
Due to its bitter taste it is not edible. 
2.5.1 Phytochemistry of Sarcodon scabrosus 
An analysis of the literature revealed that Sarcodon scabrosus (syn Hydnum scabrosus), 
together with S. imbricatus, is one of the most studied species among Sarcodon. Two classes 
of secondary metabolites have been isolated from this species, and both are represented by 
cythane diterpenes: scabronines and sarcodonins. The use of the same name for different 
classes of secondary metabolites clearly shows how the use of common names can give rise 
to mistakes.  
The first report about the isolation of cyathane diterpenes from S. scabrosus was by Shibata et 
al. (1989) and it is about sarcodonin A (21) and G (22) (Fig. 13).  
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Fig. 12. Sarcodon scabrosus (Fr.) P. Karst. 
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Fig. 13. Sarcodonins A and G 
Generally sarcodonins and neosarcodonins isolated from S. scabrosus are characterized by 
the presence of a hydroxyl-methyl group in C-19 (Kryczkowski et al., 2008).  
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Fig. 14. Isolated scabronines 
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Scabronines are characterized by the oxidation of C-17 to carboxylic group. The first 
scabronine that was isolated was scabronine A (23) (Ohta et al., 1998a) and later scabronines 
B-F (24-28) were isolated (Kita et al., 1998) (Fig. 14). 
Among different cyathane diterpenes, the most interesting for its biological properties is 
scabronine G (29) (Fig. 15), that has been isolated in 1998 (Ohta et al., 1998b). In 2004, Ma and 
coworkers reported the isolation of another scabronine G (30), but this compound is 
structurally related to sarcodonins (Ma et al., 2004). 
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Fig. 15. Structures of the two scabronines G 
Ma et al. isolated other scabronines (H-J), but they still have sarcodonins structures (Ma et 
al., 2004; Ma et al., 2008). 
From S. scabrosus in addition to the already mentioned sarcodonins A (21) and G (22) in 2002 
other three cyathane diterpenoids have been isolated (Hirota et al., 2002). Three of them 
were named neosarcodonins A-C (31-33). The same group in 2004 isolated neosarcodonin O 
(34) and three acyl derivatives of sarcodonin A (35-37) (Kamo et al., 2004) (Fig. 16). 
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Fig. 16. Neosarcodonins isolated from S. scabrosus 
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3. Biological activities of Sarcodon metabolites 
3.1 Biological activities of p-terphenyl derivatives 
Terphenyls are aromatic hydrocarbons consisting of a chain of three benzene rings. From a 
structural point of view three different isomers are possible, in which the terminal rings are 
ortho-, meta-, or para-substituents of the central ring. Most of the natural terphenyls are p-
terphenyl derivatives. In recent years, some terphenyls have been reported to exhibit 
significant biological activity, e.g., potent immunosuppressant, neuroprotective, 
antithrombotic, anticoagulant, specific 5-lipoxygenase inhibitory, and cytotoxic activities 
(Liu, 2007). 
3.1.1 Antibiotic properties 
Compounds 10 and 11 (Tringali et al., 1987) were tested against several Gram-positive and 
Gram-negative bacteria in an agar dilution test and the results showed that among Gram-
positive the most susceptible microorganism was Proteus mirabilis and among Gram-
negative Staphylococcus aureus (MIC 75 and 50 g/ml respectively).  
3.1.2 Antitumoral activity 
Sarcodonin (12) was tested against two different tumor cell lines and it resulted moderately 
active toward KB (ED50 10.0 g/ml) and P-388 (ED50 27.0 g/ml) (Geraci et al., 2000). The 
higher cytotoxic activity of 10 with respect to 12, coupled with mild antibacterial activity 
already described (Tringali et al., 1987) suggest that 10 could play a role in the chemical 
defense of the mushroom.  
Compounds 12, 13 (sarcodonin ), 15 (sarcodonin Ǆ), and 17 (episarcodonin) and the 
mixture of 19 and 20 (sarcoviolins) were tested in the three-cell line panel High Throughput 
PreScreen (one-dose primary anticancer assay) carried out at National Cancer Institute 
(Bethesda, USA). Fully aromatic terphenyls proved to be cytotoxic at a concentration of 5 
x10-5 M against NCI-H460 (Lung), MCF7 (Breast), and SF-268 (CNS) cell lines. In particular, 
12, 15, and 16 show the highest cytotoxicity towards SF-268 cells, with 96, 93, and 95% of 
cells killed, respectively. Sarcoviolins (19 and 20) significantly reduced the growth of all cell 
lines at 10-4 M (MCF7 totally blocked).  
3.2 Biological activities of cyathane diterpenoids 
In 1965 Brodie discovered a new bird’s nest fungus of the genus Cyathus that was named C. 
helenae (Brodie, 1966) and he showed that the metabolites of the mushroom (cyathine 
complex) possessed antibiotic activity (Allbutt et al., 1971). From this first report, in these 40 
years, a great number of cyathane diterpenoids have been isolated, structurally identified 
and tested for their biological activities. 
3.2.1 Antibiotic activity 
In 1998 Shibata (Shibata et al., 1998) and coworkers isolated from S. scabrosus sarcodonins L 
and M and sarcodonin A (21) and G (22). Sarcodonin L and M resulted to be identical to 
scabronines C (25) and B (24), respectively (Kita etal., 1998). All these compounds were 
tested against B. subtilis and S. aureus and the results are reported in Table 1. 
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Compound 
B. subtilis S. aureus 
1.0%* 0.2% 0.05% 1.0% 0.2% 0.05% 
21 6.5**   7.0   
22 6.5   7.5 6.5  
24 14.0 11.0 8.0 22.0 15.0 9.0 
25 9.5 7.5 7.0 18.0 12.0 7.5 
*Disc were soaked in 35 l of each test sample (w/v%); **The diameter of the inhibitory zone was 
measured in mm. 
Table 1. Antibiotic activity of sarcodonins A, G, L and M 
3.2.2 Anti-inflammatory activity 
Anti-inflammatory activity has been tested for sarcodonin A (21), sarcodonin G (22), 
neosarcodonin A-C (31-33) (Hirota et al., 2002), neosarcodonin O (34), acyl derivatives of 
sarcodonin A (35-37) (Kamo et al., 2004) and glaucopines A-C (5-7) (Curini et al., 2005; 
Marcotullio et al., 2006a). The results are reported in Table 2. The topical anti-inflammatory 
activity of compounds  was evaluated observing the reduction of oedema induced by TPA , 
for sarcodonins and neosarcodonins, and Croton oil, for glaucopines, in mouse ear. 
Indomethacin was used as positive control in all tests. 
 
Compound Dose Animals % Oedema Reduction 
5 1.0a 10 62 
6 1.0a 10 55 
7 1.0a 6 39 
Indomethacin 0.3a 10 66 
21 0.63b 5 75 
22 0.63b 5 84 
31 0.57b 5 49 
32 0.57b 5 64 
33 0.53b 5 87 
34 0.63b 5 36 
35 0.63b 5 61 
36 0.63b 5 46 
37 0.63b 5 72 
Indomethacin 0.56b 5 16 
a Dose= Moles/cm2; b Dose= mol 
Table 2. Anti-inflammatory activity of sarcodonins, neosarcodonins and glaucopines 
3.2.3 Antiproliferative and antitumoral activities 
The first report about the antitumor activity of a cyathane diterpene was about sarcodonin G  
isolated from the dichloromethane extract of Sarcolon scabrosus Karst, on HeLa cells in vitro.   
Sarcodonin G (22), isolated from the mushroom Sarcodon scabrosus and already reported to 
have anti-inflammatory activity, inhibited proliferation of HeLa cells (Dong et al., 2009).  
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3.2.4 Stimulation of NGF (Nerve Growth Factor) 
Sarcodon scabrosus and S. cyrneus metabolites have been studied for their unique activity to 
act as neuroprotective agents being able to stimulate the production of neurotrophic factors 
in vitro. Scabronines A-G (23-29) have been tested for their activity to induce NGF secretion 
from 1321N1 human astrocytoma cells and induce neuritogenesis in PC12 cells (rat 
pheochromocytoma cells) (Ohta et al., 1998a, 1998b; Kita et al., 1998; Oshima, Y. et al., 1999).  
Scabronines increased the expression of mRNA for NGF, and the secretion of NGF from 
1321N1 cells in a concentration-dependent mechanism (Obara et al., 1999). Among different 
scabronines, scabronine G methyl ester (SG-ME) (31) resulted to be the most active and the 
mechanism of action was deeply studied. SG-ME activates PKC-ζ, induces the translocation 
NF-κB to nucleus and enhances its transcriptional activity (Fig. 17) (Obara et al., 2001). 
Cyrneine A-D (1-4) and glaucopine C (7) were tested to evaluate their activity to induce NGF 
production from 1321N1 cells, but they resulted much less active than scabronine G (Fig. 18) 
(Marcotullio et al., 2007). Neverthless, cyrneine A and B showed an interesting activity, being 
able to induce directly differentiation on PC-12 cells (Marcotullio et al., 2006b). 
 
 
Fig. 17. Morphological changes of PC-12 cells by the 1321N1 cell culture medium 
conditioned by scabronines. NGF used as control. 
 
*
*
*
*
*
*
*
 
Fig. 18. Evaluation of NGF synthesis from 1321N1 induced by cyrneines and glaucopine C. 
SG-ME used as control. 
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As a transcriptional regulation is required for neurite extension, and the activity of three 
major transcription factors (activator protein-1 (AP-1), nuclear factor-κB, and CREB) was 
determined. Cyrneines A and B enhanced activation of AP-1 and NF-κB. Moreover, 
treatment with cyrneine A led to actin translocation and subsequently, to accumulation of F-
actin at the tip of neurites.  Rac1 activity was increased by cyrneine A and expression of a 
dominant-negative Rac1 mutant significantly inhibited the cyrneine A-induced extension of 
neurites.  These results suggest that cyrneine A induces neurite outgrowth in a Rac1-
dependent mechanism (Obara et al., 2007). 
4. Conclusions 
The analysis of the literature about Sarcodon genus showed that these mushrooms produces 
interesting biologically active secondary metabolites such as cyathane e triphenyl 
derivatives. It is interesting to note that the use of  trivial names instead of systematic ones 
generated some confusion (e.g. the term sarcodonins has been used to name both terphenyls 
and  cyathanes). Furthermore, it was evidenced that sometimes there are problems in the 
use of different synonyms for the same species. Neverthless, the interesting biological 
properties of Sarcodon metabolites and the nutritional value of some spp make this genus 
worthy of further investigations.  
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